Despite High Cost, Improved Pneumococcal Vaccine Expected To Return 10-Year Net Savings Of $12 Billion.
Saved in:
| Title: | Despite High Cost, Improved Pneumococcal Vaccine Expected To Return 10-Year Net Savings Of $12 Billion. |
|---|---|
| Authors: | Kohli, Michele A.1 michele.kohli@optum.com, Farkouh, Raymond A.2, Maschio, Michael J.3, McGarry, Lisa J.4, Strutton, David R.5, Weinstein, Milton C.6 |
| Source: | Health Affairs. Jul2015, Vol. 34 Issue 7, p1234-1240. 7p. |
| Database: | Academic Search Ultimate |
| ISSN: | 02782715 |
|---|---|
| DOI: | 10.1377/hlthaff.2014.1274 |
